{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:30:38Z","timestamp":1761129038973},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,10,6]],"date-time":"2012-10-06T00:00:00Z","timestamp":1349481600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s11695-012-0747-4","type":"journal-article","created":{"date-parts":[[2012,10,5]],"date-time":"2012-10-05T05:47:22Z","timestamp":1349416042000},"page":"145-149","source":"Crossref","is-referenced-by-count":11,"title":["Cumulative Helicobacter pylori Eradication Therapy in Obese Patients Undergoing Gastric Bypass Surgery"],"prefix":"10.1007","volume":"23","author":[{"given":"Rute M.","family":"Cerqueira","sequence":"first","affiliation":[]},{"given":"Manuel R.","family":"Correia","sequence":"additional","affiliation":[]},{"given":"Carolina D.","family":"Fernandes","sequence":"additional","affiliation":[]},{"given":"H\u00e9lder","family":"Vilar","sequence":"additional","affiliation":[]},{"given":"M. Concei\u00e7\u00e3o","family":"Manso","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2012,10,6]]},"reference":[{"key":"747_CR1","first-page":"1565","volume":"48","author":"M Quina","year":"2001","unstructured":"Quina M, Guerreiro A. Gastric cancer (carcinoma) and Helicobacter pylori: situation in Portugal. Hepato Gastroenterol. 2001;48:1565\u20138.","journal-title":"Hepato Gastroenterol"},{"key":"747_CR2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/annonc\/mdl498","volume":"18","author":"J Ferlay","year":"2007","unstructured":"Ferlay J, Autier P, Boniol M, et al. Estimates of cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007;18:581\u201392.","journal-title":"Ann Oncol"},{"issue":"9","key":"747_CR3","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s11695-010-0254-4","volume":"21","author":"RM Cerqueira","year":"2011","unstructured":"Cerqueira RM, Manso MC, Correia MR, et al. Helicobacter pylori eradication therapy in obese patients undergoing gastric by-pass surgery\u2014fourteen days superior to seven days? Obes Surg. 2011;21(9):1377\u201381.","journal-title":"Obes Surg"},{"key":"747_CR4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/sj.ijo.0803560","volume":"31","author":"M Fried","year":"2007","unstructured":"Fried M, Hainer V, Basdevant A, et al. European guidelines on surgery of severe obesity. Int J Obes. 2007;31:569\u201377.","journal-title":"Int J Obes"},{"key":"747_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gie.2008.01.028","volume":"68","author":"ASGE Guidelines","year":"2008","unstructured":"ASGE Guidelines. Role of endoscopy in the bariatric patient. Gastrointest Endosc. 2008;68:1\u201310.","journal-title":"Gastrointest Endosc"},{"key":"747_CR6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2036.2002.01169.x","volume":"16","author":"P Malfertheiner","year":"2002","unstructured":"Malfertheiner P, Megraud F, O\u2019Morain C, et al. Current concepts in the management of Helicobacter pylori infection. The Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther. 2002;16:167\u201380.","journal-title":"Aliment Pharmacol Ther"},{"key":"747_CR7","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/gut.2006.101634","volume":"56","author":"P Malfertheiner","year":"2007","unstructured":"Malfertheiner P, Megraud F, O\u2019Morain C, et al. Current concepts in the management of Helicobacter pylori infection. The Maastricht III Consensus Report. Gut. 2007;56:772\u201381.","journal-title":"Gut"},{"key":"747_CR8","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/gut.2009.192757","volume":"59","author":"DY Graham","year":"2010","unstructured":"Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut. 2010;59:1143\u201353.","journal-title":"Gut"},{"key":"747_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00042737-199701000-00002","volume":"9","author":"P Malfertheiner","year":"1997","unstructured":"Malfertheiner P, Megraud F, O\u2019Morain C, et al. Current European concepts in the management of Helicobacter pylori infection\u2014the Maastricht I Consensus Report. The European Helicobacter Pylori Study Group (EHPSG). Eur J Gastroenterol Hepatol. 1997;9:1\u20132.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"747_CR10","unstructured":"WHO. The global burden of disease. 2004 update (online), http:\/\/www.who.int\/healthinfo\/globalburdendisease\/2004reportupdate\/en\/index\/html (2008)."},{"key":"747_CR11","doi-asserted-by":"crossref","first-page":"e 442","DOI":"10.1371\/journal.pmed.0030442","volume":"3","author":"CD Mathers","year":"2006","unstructured":"Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e 442.","journal-title":"PLoS Med"},{"key":"747_CR12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1023\/A:1005444006042","volume":"45","author":"DJ Kearney","year":"2000","unstructured":"Kearney DJ, Brousal A, et al. Treatment of Helicobacter pylori infection in clinical practice in the United States. Dig Dis Sci. 2000;45:265\u201371.","journal-title":"Dig Dis Sci"},{"key":"747_CR13","first-page":"30","volume":"1","author":"RJ Saad","year":"2006","unstructured":"Saad RJ, Chey WD. Treatment of Helicobacter pylori infection in 2006. Gastroenterol Hepatol Ann Rev. 2006;1:30\u20135.","journal-title":"Gastroenterol Hepatol Ann Rev"},{"key":"747_CR14","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/j.clinthera.2006.11.011","volume":"28","author":"A Kadayifci","year":"2006","unstructured":"Kadayifci A, Buyukhatipoglu H, Cemil Savas M, et al. Eradication of Helicobacter pylori with triple therapy: an epidemiological analysis of trends in Turkey over 10\u00a0years. Clin Ther. 2006;28:1960\u20136.","journal-title":"Clin Ther"},{"key":"747_CR15","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1136\/gut.2003.022111","volume":"53","author":"F M\u00e9graud","year":"2004","unstructured":"M\u00e9graud F. H. pylori antibiotic resistance: prevalence, importance and advances in testing. Gut. 2004;53:1374\u201384.","journal-title":"Gut"},{"key":"747_CR16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/jac\/46.2.283","volume":"46","author":"JA Sanchez","year":"2000","unstructured":"Sanchez JA, Saenz NG, Rincon MR, et al. Susceptibility of Helicobacter pylori to mupirocin, oxazolidinones, quinupristin\/dalfopristin and new quinolones. J Antimicrob Chemother. 2000;46:283\u20135.","journal-title":"J Antimicrob Chemother"},{"key":"747_CR17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.0083-8703.2006.00375.x","volume":"11","author":"D Antos","year":"2006","unstructured":"Antos D, Schneider-Brachert W, Bastlein E, et al. 7-day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin and high dose esomeprazole in patients with known antimicrobial sensitivity. Helicobacter. 2006;11:39\u201345.","journal-title":"Helicobacter"},{"key":"747_CR18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.diagmicrobio.2005.12.003","volume":"55","author":"J Yahav","year":"2006","unstructured":"Yahav J, Shmuely H, Niv Y, et al. In vitro activity of levofloxacin against Helicobacter pylori isolates from patients after treatment failure. Diagn Microbiol Infect Dis. 2006;55:81\u20133.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"747_CR19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2036.2006.02737.x","volume":"23","author":"P Gisbert","year":"2006","unstructured":"Gisbert P, Morena F. Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure. Aliment Pharmacol Ther. 2006;23(1):35\u201344.","journal-title":"Aliment Pharmacol Ther"},{"key":"747_CR20","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1572-0241.2006.00637.x","volume":"101","author":"RJ Saad","year":"2006","unstructured":"Saad RJ, Schoenfeld P, Kim HM, et al. Levofloxacin based triple therapy versus bismuth based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis. Am J Gastroenterol. 2006;101:488\u201396.","journal-title":"Am J Gastroenterol"},{"key":"747_CR21","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/jac\/46.6.1029","volume":"46","author":"J Cabrita","year":"2000","unstructured":"Cabrita J, Oleastro M, Matos R. Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990\u20131999). J Antimicrob Chemother. 2000;46:1029\u201331.","journal-title":"J Antimicrob Chemother"},{"key":"747_CR22","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1365-2036.2011.04887.x","volume":"34","author":"JP Gisbert","year":"2011","unstructured":"Gisbert JP, Calvet X. Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade but is not good enough. Aliment Pharmacol Ther. 2011;34:1255\u201368.","journal-title":"Aliment Pharmacol Ther"},{"key":"747_CR23","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2036.2007.03573.x","volume":"27","author":"JP Gisbert","year":"2008","unstructured":"Gisbert JP, Gisbert JL, Marcos S, et al. Empirical rescue therapy after Helicobacter pylori treatment failure. A 10\u00a0year single center study of 500 patients. Aliment Pharmacol Ther. 2008;27:346\u201354.","journal-title":"Aliment Pharmacol Ther"},{"key":"747_CR24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ajg.2008.87","volume":"104","author":"T Rokkas","year":"2009","unstructured":"Rokkas T, Sechopoulos P, Robotis I, et al. Cumulative H. pylori eradication rates in clinical practice by adopting first and second line regimens proposed by the Maastricht III consensus and a third line empirical regimen. Am J Gastroenterol. 2009;104:21\u20135.","journal-title":"Am J Gastroenterol"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-012-0747-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11695-012-0747-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-012-0747-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T12:15:29Z","timestamp":1562242529000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11695-012-0747-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,6]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["747"],"URL":"https:\/\/doi.org\/10.1007\/s11695-012-0747-4","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,6]]}}}